8 Days After the FDA: Breaking Down HRT and Breast Cancer Risk with Dr. Corinne Menn
About this episode
Sharon Kedar interviews Dr. Corinne Menn to discuss the relationship between hormone therapy and breast cancer risk following a recent FDA announcement.
On this episode of Innovate & Elevate, Sharon sits down with Dr. Corinne Menn, an OB-GYN, menopause specialist, and breast cancer survivor, to unpack one of the most misunderstood topics in women’s health: the relationship between breast cancer risk and hormone therapy. Recorded eight days after the FDA announced it will remove the long-standing black box language on hormone therapy, this conversation traces the legacy of the 2002 Women’s Health Initiative press conference, what the data actually showed, and how modern evidence can better guide women and their clinicians today. What You’ll Learn from this Episode: What really happened in July 2002, and why the WHI press conference (held eight days before doctors saw the full study) reshaped hormone therapy for a generation. The difference between estrogen alone and combined estrogen–progestin therapy, and why age, timing, and formulation matter. Why every major professional society (ASCO, ACOG, American Urological Association, The Menopause Society) agrees that local, low-dose vaginal hormones do not increase breast cancer risk, recurrence, or mortality. The role of tools like the Tyrer–Cuzick breast cancer risk model in…
More episodes of Innovate and Elevate
- 1993: The Year Women Entered Clinical Trials & Why This Matters for Human Health (With Jessica Federer)
- Shapeshifting Human Health: One Medical’s 30 Year Journey with Former CEO Amir Dan Rubin
- Redefining Risk with Dr. Michael Rubin: On Entrepreneurship, Career Decisions, and Building Venture Capital in Human Health
- Building a Better Menopause System: Insights from One Medical’s Dr. Erin Duralde
- Special Episode with Dr. Kelly Casperson on Hormone Replacement Therapy (HRT)
- Menopause is Hot with Joanna Strober, CEO of Midi Health
Explore listener stats, chart rankings, contacts and more on the Innovate and Elevate podcast page.